Sichuan Biokin Pharmaceutical's Unit Receives Milestone Payment From Bristol-Myers Squibb

By Reuters News

- Sichuan Biokin Pharmaceutical Co Ltd 688506.SS:

  • SAYS UNIT RECEIVED SECOND MILESTONE PAYMENT OF $250 MILLION FROM BRISTOL-MYERS SQUIBB FOR IZA-BREN AGREEMENT

Source text

Further company coverage: 688506.SS

Capital Com is an execution-only service provider. The present material must be regarded as marketing communication and should not be interpreted as investment research or investment advice. Any opinion that may be provided on this page does not constitute a recommendation by Capital Com or its agents. We do not make any representations or warranty on the accuracy or completeness of the information that is provided on this page. If you rely on the information on this page, then you do so entirely at your own risk